Sinovent Inc Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$98.1M
- Investors
-
21
Sinovent Inc General Information
Description
Researcher and developer of bio[bio-pharmaceutical products designed to provide medical products and solutions to treat diseases. The company currently has 12 research products covering therapeutic fields including tumor, central nervous system, autoimmunity and infection, enabling patients to utilize advanced treatment methods and improve their overall health.
Contact Information
Website
www.evopointbio.comCorporate Office
- Building 22, Phase II, Bio-Industrial Park
- No. 218 Sangtian Road, Suzhou Industrial Park
- Suzhou, Jiangsu
- China
Corporate Office
- Building 22, Phase II, Bio-Industrial Park
- No. 218 Sangtian Road, Suzhou Industrial Park
- Suzhou, Jiangsu
- China
Sinovent Inc Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series E) | 20-Feb-2024 | $98.1M | Completed | Clinical Trials - General | ||
| 5. Later Stage VC | 31-Dec-2020 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series C) | 25-Aug-2020 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series B) | 26-Jun-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Apr-2018 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 28-Nov-2017 | Completed | Generating Revenue |
Sinovent Inc Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sinovent Inc Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sinovent Inc Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chenhai Capital | Venture Capital | Minority | ||
| Jinan Industrial Development Investment Group | Government | Minority | ||
| PDVC | Venture Capital | Minority | ||
| Shanghai Guoxin Investment | Corporate Venture Capital | Minority | ||
| Suzhou Asset Management | Asset Manager | Minority |
Sinovent Inc Investments (1)
Sinovent Inc’s most recent deal was a Early Stage VC with MediLink Therapeutics. The deal was made on 13-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MediLink Therapeutics | 13-Dec-2020 | Early Stage VC | Drug Discovery |
Sinovent Inc FAQs
-
When was Sinovent Inc founded?
Sinovent Inc was founded in 2017.
-
Where is Sinovent Inc headquartered?
Sinovent Inc is headquartered in Suzhou, China.
-
What is the size of Sinovent Inc?
Sinovent Inc has 50 total employees.
-
What industry is Sinovent Inc in?
Sinovent Inc’s primary industry is Drug Discovery.
-
Is Sinovent Inc a private or public company?
Sinovent Inc is a Private company.
-
What is Sinovent Inc’s current revenue?
The current revenue for Sinovent Inc is .
-
How much funding has Sinovent Inc raised over time?
Sinovent Inc has raised $242M.
-
Who are Sinovent Inc’s investors?
Chenhai Capital, Jinan Industrial Development Investment Group, PDVC, Shanghai Guoxin Investment, and Suzhou Asset Management are 5 of 21 investors who have invested in Sinovent Inc.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
